Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06EIO
|
|||
| Former ID |
DIB016204
|
|||
| Drug Name |
Trimelamol
|
|||
| Synonyms |
NSC-283162
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Discontinued in Phase 2 | [1] | |
| Company |
Institute of Cancer Research UK
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H18N6O3
|
|||
| Canonical SMILES |
CN(CO)C1=NC(=NC(=N1)N(C)CO)N(C)CO
|
|||
| InChI |
1S/C9H18N6O3/c1-13(4-16)7-10-8(14(2)5-17)12-9(11-7)15(3)6-18/h16-18H,4-6H2,1-3H3
|
|||
| InChIKey |
MHVFYGIQJNFWGQ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 64124-21-6
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004905) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.